Rite Aid (NYSE: RAD)
You’re reading a free stock page from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
Rite Aid Returns vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Rite Aid Company Info
The Company is a Delaware corporation and through its wholly-owned subsidiaries, operates retail drugstores in the United States of America.
News & Analysis
The pharmacy chain could still be the target of activist investors.
The pharmacy chain's earnings report was just what the doctor ordered.
These investments seem pretty vulnerable right now.
There's a lot going wrong, and not much going right.
The company's financials aren't great -- but should investors be worried?
The company provided a better-than-expected outlook for fiscal 2023.
An analyst gave a bleak outlook for the pharmacy stock.
Surging COVID-19 testing and fewer stores could mean more profits for investors.
Motley Fool Returns
Market-beating stocks from our award-winning analyst team.
Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/24/2022.
Discounted offers are only available to new members. Stock Advisor list price is $199 per year.
Calculated by Time-Weighted Return since 2002. Volatility profiles based on trailing-three-year calculations of the standard deviation of service investment returns.
Valuation
Earnings Transcripts
RAD earnings call for the period ending March 31, 2022.
RAD earnings call for the period ending March 31, 2022.
RAD earnings call for the period ending September 30, 2021.
RAD earnings call for the period ending June 30, 2021.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.